Skip to main content
. 2023 Nov 7;9(11):e21228. doi: 10.1016/j.heliyon.2023.e21228

Table 1.

Characteristics of included studies.

No. First author Year Location Number (Intervnetion/Control) Intervention Control Study design Time Dose Health condition Weight management
1 I-Ju Chen [18] 2016 China 77(39/38) Green tea Extract capsules Cellulose Randomized double-blind control 12 weeks 857 mg EGCG Health No
2 Joanna Suliburska [19] 2012 Poland 46(23/23) Green tea Extract capsules Cellulose Randomized double-blind control 3 months 208 mg EGCG Health No
3 Juan Mielgo-Ayuso [20] 2014 Spain 83(43/40) Green tea Extract Lactin Randomized double-blind control 12 weeks 300 mg EGCG Health Yes
4 Chung-Hua Hsu [21] 2008 China 78(41/37) Green tea Extract capsules Cellulose Randomized double-blind control 12 weeks 400 mg EGCG Health No
5 Justin D. Roberts [22] 2021 UK 18(9/9) Green tea Extract Cellulose Randomized single blind control 8 weeks 400 mg EGCG Health Yes
6 Chung-Hua Hsu [23] 2011 China 68(35/33) Green tea Extract Cellulose Randomized double-blind control 16 weeks 857 mg EGCG Type 2 diabetes No
7 K. Diepvens [24] 2006 Netherlands 46(23/23) Green tea Extract Cellulose Randomized double-blind control 12 weeks 267 mg EGCG Health Yes
8 Joanna Bajerska [25] 2015 Poland 44(23/21) Green tea extract additive Blank Randomized single blind control 12 weeks 242 mg EGCG Health Yes
9 Tengfei Zhang [26] 2020 China 24(12/12) Green tea Extract Cellulose Randomized double-blind control 12 weeks 300 mg EGCG Health No
10 Pawel Bogdanski [27] 2012 Poland 56(28/28) GTE capsules Cellulose Randomized double-blind control 3 months 208 mg EGCG Hypertension No
11 Lin-Huang Huang [28] 2018 China 73(37/36) GTE capsules Cellulose Randomized, double-blind, cross-over control 6 weeks 857 mg EGCG High LDL-c No